LMCG Investments’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.6M Sell
20,478
-579
-3% -$592K 1.32% 19
2026
Q1
$19.4M Buy
21,057
+978
+5% +$992K 1.15% 23
2025
Q4
$21.6M Sell
20,079
-789
-4% -$754K 1.23% 20
2025
Q3
$15.9M Buy
20,868
+9,556
+84% +$7.11M 0.94% 27
2025
Q2
$8.82M Buy
11,312
+1,249
+12% +$971K 0.55% 66
2025
Q1
$8.31M Sell
10,063
-173
-2% -$144K 0.55% 64
2024
Q4
$7.9M Sell
10,236
-372
-4% -$308K 0.48% 73
2024
Q3
$9.4M Sell
10,608
-540
-5% -$485K 0.56% 69
2024
Q2
$10.1M Sell
11,148
-331
-3% -$265K 0.59% 63
2024
Q1
$8.93M Sell
11,479
-1,038
-8% -$739K 0.53% 74
2023
Q4
$7.3M Sell
12,517
-335
-3% -$196K 0.45% 78
2023
Q3
$6.9M Sell
12,852
-48
-0.4% -$24.7K 0.47% 76
2023
Q2
$6.05M Buy
12,900
+3,056
+31% +$1.28M 0.39% 91
2023
Q1
$3.38M Buy
9,844
+3,346
+51% +$1.13M 0.23% 116
2022
Q4
$2.38M Hold
6,498
0.17% 139
2022
Q3
$2.1M Sell
6,498
-50
-0.8% -$15.8K 0.15% 150
2022
Q2
$2.12M Buy
6,548
+1,084
+20% +$325K 0.15% 151
2022
Q1
$1.56M Buy
+5,464
New +$1.41M 0.09% 206
2015
Q3
$1.66M Sell
19,779
-750
-4% -$63.3K 0.04% 375
2015
Q2
$1.71M Hold
20,529
0.04% 371
2015
Q1
$1.49M Hold
20,529
0.03% 385
2014
Q4
$1.42M Sell
20,529
-250
-1% -$16.9K 0.03% 370
2014
Q3
$1.35M Sell
20,779
-933
-4% -$59.1K 0.03% 371
2014
Q2
$1.35M Buy
21,712
+2,733
+14% +$163K 0.03% 368
2014
Q1
$1.12M Hold
18,979
0.02% 380
2013
Q4
$968K Hold
18,979
0.02% 381
2013
Q3
$955K Sell
18,979
-8,525
-31% -$446K 0.02% 359
2013
Q2
$1.35M Buy
+27,504
New +$1.5M 0.04% 336

Other funds holding LLY

LMCG Investments's LLY Position: Q2 2026 in Review

LMCG Investments reduced its Eli Lilly (LLY) stake by 2.7% in Q2 2026, selling an estimated $592K and leaving 20,478 shares worth $24.6M. The position accounts for 1.32% of the portfolio, ranked #19.

LMCG Investments first reported a position in LLY in Q2 2013 and has held it in 28 quarters since. 3,039 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LMCG Investments held 20,478 shares of Eli Lilly worth $24.6M as of Q2 2026.
  • LMCG Investments sold 579 Eli Lilly shares in Q2 2026, an estimated $592K.
  • Eli Lilly made up 1.32% of LMCG Investments's portfolio in Q2 2026, its #19 holding.
  • LMCG Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 28 quarters since.
  • 3,039 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LMCG Investments's 13F filing for Q2 2026, filed 22 Jul 2026.